ABBV•benzinga•
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Summary
JP Morgan highlights 2025 growth prospects for biopharma, animal health, and specialty pharma stocks. Key picks include Eli Lilly, Zoetis, and Bristol-Myers Squibb.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 22, 2024 by benzinga